Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Alimentary Pharmacology & Therapeutics
|
September 24, 2024
Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM
Lina Hountondji, Stéphanie Faure, Pascale Palassin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 25, 2022
Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany
Frank Griesinger, Maurice Pérol, Nicolas Girard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Claire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 21, 2021
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
Marie Wislez, Charlotte Domblides, Laurent Greillier, et al.
Journal of Clinical Medicine
|
February 11, 2023
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
Karl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
JHEP Reports : Innovation in Hepatology
|
May 4, 2023
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
Lina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 5, 2017
Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Clémence Basse, Sébastien Thureau, Suzanna Bota, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 30, 2023
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, et al.
Targeted Oncology
|
October 18, 2021
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
Christos Chouaid, Thomas Filleron, Didier Debieuvre, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Alimentary Pharmacology & Therapeutics
|
September 24, 2024
Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM
Lina Hountondji, Stéphanie Faure, Pascale Palassin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 25, 2022
Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany
Frank Griesinger, Maurice Pérol, Nicolas Girard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Claire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 21, 2021
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
Marie Wislez, Charlotte Domblides, Laurent Greillier, et al.
Journal of Clinical Medicine
|
February 11, 2023
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
Karl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
JHEP Reports : Innovation in Hepatology
|
May 4, 2023
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
Lina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 5, 2017
Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Clémence Basse, Sébastien Thureau, Suzanna Bota, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 30, 2023
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, et al.
Targeted Oncology
|
October 18, 2021
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
Christos Chouaid, Thomas Filleron, Didier Debieuvre, et al.
Page
of 9